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TO THE EDITOR
Osteopontin is a secreted arginine-
glycine-aspartate (RGD)-containing phos-
phoglycoprotein that interacts with
different cell-surface receptors, includ-
ing avb3, avb5, a4b1, a9b1, and
certain CD44 isoforms (Denhardt
et al., 2001; Sodek et al., 2006; Scatena
et al., 2007). Osteopontin (OPN) has
been implicated to have important
cytokine and chemokine functions in
Th1/Tc1-mediated immunity against
viral and bacterial pathogens and in
type-1-mediated diseases such as rheu-
matoid arthritis, autoimmune encepha-
litis, and granuloma formation (Ashkar
et al., 2000; Diao et al., 2004; Tanaka
et al., 2004; Shinohara et al., 2005;
Hur et al., 2007). We demonstrated that
OPN-null mice are impaired in their
capacity to mount allergic contact
hypersensitivity against trinitro-chloro-
benzene (TNCB) (Weiss et al., 2001).
The initiation of Th1-mediated immu-
nity depends upon the function of
antigen-presenting myeoloid dendritic
cells (DCs) (Banchereau et al., 2000;
Kapsenberg 2003). Contact hypersensi-
tivity is a Th1-mediated immune re-
sponse that is elicited once a hapten
has been recognized during the initial
sensitization phase. DCs are central to
the sensitization process, as they recog-
nize and transport the allergen into skin
draining lymph nodes for presentation
to naive T cells (Romani et al., 2006).
OPN is likely to influence contact
hypersensitivity response because it
activates DCs and induces their matu-
ration toward an IL-12 secreting, Th1-
polarizing phenotype (Renkl et al.,
2005). We previously described that
OPN is chemotactic for DCs and OPN-
null mice are impaired in their capacity
to attract DCs to skin draining lymph
nodes (Weiss et al., 2001). As we and
others found that myeloid DCs produce
OPN when differentiating from mono-
cytes, we went on to investigate the role
of autocrine effects of OPN produced
by DCs themselves (Kawamura et al.,
2005; Renkl et al., 2005). As convin-
cing evidence exists that the migratory
phenotype of macrophages, endothelial
cells, and various types of tumour cells
is associated with a high OPN-expres-
sing phenotype, we determined which
factors regulate OPN expression during
murine DC maturation and investigated
the role of DC-expressed OPN for their
migratory abilities (Bruemmer et al.,
2003; Rangaswami et al., 2006; Sodek
et al., 2006; Nystrom et al., 2007).
In murine bone marrow cultures, we
found that under the addition of GM-
CSF and IL-4 OPN mRNA and protein
secretion increased constantly from
day 3 to 7 of DC maturation (Figure
1a and b). When separating CD11cþ
DC from bone marrow cultures, these
were the major OPN-secreting cells as
they expressed high levels of OPN
mRNA in contrast to the CD11c-
depleted fraction (Figure 1c). Our find-
ings demonstrate that OPN expression
is strongly upregulated early during
DC differentiation from bone marrow
precursors. The fact that immature DCs
highly express OPN is interesting espe-
cially as other immune cells, such
as T cells, NK-cells, and monocytes,
express OPN only following their
activation in an inflammatory context
(Shinohara et al., 2005; Sodek et al.,
2006; Hur et al., 2007).
Both tumor-necrosis factor-a (TNF-a)
and IL-1a induce a highly migratory
phenotype in DCs (Cumberbatch et al.,
2002). To establish a possible corre-
lation between the migratory pheno-
type of DCs and their OPN-secreting
potential, DCs were stimulated with
TNF-a, IL-1a, or lipopolysaccharide
(LPS). TNF-a and IL1-a induced OPN
secretion (Figure 1d and e). Whereas
IL-4 only moderately downmodulated
OPN expression, LPS that induces
terminally activated, non-migratory
DCs strongly inhibited their OPN secre-
tion, which was not due to significantly
reduced viability (Figure 1d and e). In
Boyden chamber assays, we investi-
gated how the level of OPN secretion
correlates with the migratory potential
of DCs (Figure 1e). Indeed, the highly
OPN-secreting, TNF-a- or IL-1a-treated
DCs efficiently migrated toward TNF-a
(Figure 1e). In contrast, LPS-matured,
low OPN secreting DCs were non-
migratory (Figure 1e). Similar to our
findings with DCs, it was described that
LPS suppresses OPN in macrophages
(Shinohara et al., 2006), however, not
correlating this OPN-low state with
migration. We can only speculate that
LPS in both cell types may induce a low
OPN-expressing less migratory pheno-
type.
To demonstrate that OPN deficiency
is sufficient to influence DC migratory
function, DCs generated from wild type
and OPN-null mice were compared in
their potential to migrate toward TNF-a,
OPN, and CCL19. Whereas OPN wild-
type DCs showed the previously des-
cribed migration toward TNF-a, OPN,
and CCL19, OPN-deficient DCs were
unable to sufficiently migrate toward
any of these stimuli (Figure 2a and b).
Interestingly, in both monocytes and
DCs, the high OPN-expressing state is
correlated with high mobility. In vivo,
macrophages migrating toward der-
mally injected N-formyl-met-leu-phe
highly express OPN and Nystrom
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et al. (2007) recently reported that
silencing of OPN expression by RNA
interference impaired macrophage
migration in vitro (Giachelli et al.,
1998).
To demonstrate that OPN expression
also correlates with DC migratory
potential in vivo, fluorescently labeled
wild-type DCs or OPN-deficient DCs
were injected into the abdominal skin
of wild-type mice (Lappin et al., 1999).
Quantitative fluorescence-activated
cell sorting analysis of pooled inguinal
and axillary lymph nodes revealed that
OPN-deficient DCs are significantly
limited in their migratory efficiency into
skin draining lymph nodes (Figure 2c).
These data provide evidence that auto-
crine OPN production is centrally
involved in DC migratory abilities.
The mechanism by which OPN
mediates DC migration remains to be
elucidated. Chemokine receptors CCR5
and CCR7 are both crucially involved
in migration of DCs. We speculated
that these receptors are modulated by
OPN. However, DC treatment by re-
combinant OPN revealed that their
expression is not influenced by OPN
(data not shown). In addition to the
secreted form, an intracellular form of
OPN may be important for DC migra-
tion by modulating CD44 activity, as
described for peritoneal macrophages
(Zohar et al., 2000; Zhu et al., 2004).
Because we have previously shown that
CD44 isoforms are involved in DC
migration, further investigations on the
role of the intracellular form of OPN in
DC migration are under way (Weiss
et al., 1997).
In conclusion, our work demon-
strates that OPN is highly expressed
by myeloid DCs and is differentially
modulated by DC-stimulating factors.
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Figure 1. Upregulation of constitutive OPN secretion by TNF-a and IL-1a correlates with the migratory capacity of DCs. DCs were generated from
bone marrow of mice (C57BL/6) in the presence of GM-CSF (40 ngml1; PromoCell, Heidelberg, Germany) and IL-4 (10 ngml1; Cell Concepts, Umkirch,
Germany) for 5 or 6 days as described previously (Weiss et al., 2001). During DC differentiation, supernatants and cells were obtained daily. In all the figures,
data representative of at least four independent experiments is shown. (a) OPN concentration in supernatants obtained on the indicated days of culture was
measured by OPN specific ELISA (IBL-Japan, Gunma, Japan) according to the manufacturer’s instructions. (b) OPN quantitative real-time PCR of cells harvested
on the indicated days was performed with a LightCycler (Roche Diagnostics, Mannheim, Germany) using the following primers: OPN (108-bp product): sense,
50-GGTGATAGCTTGGCTTATGGACTG-30; antisense, 50-GCTCTTCATGTGAGAGGTGAGGTC-30; glyceraldehyde-3-phosphate dehydrogenase (147-bp
product): sense, 50-TGGCCTTCCGTGTTCCTACC-30; antisense, 50-GGTCCTCAGTGTAGCCCAAGATG-30. Thermocycling conditions were as follows: hold at
95 1C for 15minutes, 40 cycles of 95 1C for 15 seconds, 60 1C for 20 seconds, and 72 1C for 10 seconds followed by melting-curve analysis. The relative
expression of target gene in different samples was normalized to the endogenous glyceraldehyde-3-phosphate dehydrogenase and was calculated with the
2DDCt method (Livak et al., 2001). (c) For further DC enrichment, CD11cþ cells were positively selected by magnetic cell sorting (Miltenyi, Bergisch Gladbach,
Germany) and quantitative real-time PCR was performed for OPN as described above. Unseparated bone marrow DC culture cells were used as control. (d) DCs
were harvested from bone marrow cultures on day 5, washed, replated (1 Mio. cells per well) and stimulated with LPS (serotype 0111:B4; Sigma-Aldrich,
Hamburg, Germany) at the indicated concentrations. Viability was determined by propidium iodide staining by fluorescence-activated cell sorting and did not
significantly differ for unstimulated controls and the indicated LPS concentrations (93–95% viability, after 48 hours of culture). (e) DCs were harvested from bone
marrow cultures on day 5, washed and cultured with or without GM-CSF (20 ngml1) for 48 hours without additional cytokines, GM-CSF or as indicated
additional IL-4 (5 ngml1), TNF-a (100Uml1; Cell Concepts), IL-1a (500 pgml1; Cell Concepts) or LPS (1 mgml1, serotype 0111:B4; Sigma-Aldrich) at
0.5 Mio. Cells per well. Supernatants were obtained after 48 hours of stimulation to detect OPN concentration by ELISA. To investigate the effect of OPN
production on their migratory capacity, DCs were compared in their migratory function towards TNF-a in modified Boyden chamber assays. Cells that
had migrated to the filter bottom were quantified counting four ocular grids ( 40). Results are expressed as mean number of migrated cells per mm2 ±SD
of six chambers. *Statistically significant compared with GM-CSF control (t-test Po0.001).
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In vivo and in vitro optimal DC migra-
tion depends on the expression of
OPN.
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Figure 2. OPN-deficient DCs are impaired in their capacity to migrate in vitro and to enter skin
draining lymph nodes in vivo. DCs were generated from bone marrow of OPN-deficient C57BL/6 mice
(/) (tenth generation of backcrossing) and wild-type littermates (þ /þ ) for 6 days and used in Boyden
chamber migration assays to migrate toward (a) OPN (2.5 mgml1, recombinant OPN), (a) TNF-a (50 and
250Uml1), or (b) CCL19, R&D Systems, Wiesbaden, Germany (100 or 300 ngml1). Hank’s balanced
salt solution medium was used as control. Cells that had migrated to the filter bottom were quantified as
described above. *Statistically significant compared with corresponding þ /þ DCs (t-test Po0.001).
Representative data of four independent experiments is shown. (c) In vivo DC migration assays were
performed as described previously (Lappin et al., 1999). All animal protocols were approved by the local
Committee of Animal Research. DCs were generated from OPN-null (/) C57BL/6 mice or wild-type
littermates (þ /þ ) and labeled with PKH2-GL (Sigma Immunochemicals, Hamburg, Germany) and injected
at 250,000 DCs in 30ml of phosphate-buffered saline into each quadrant of the abdominal skin of wild-type
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Inguinal and axillary lymph nodes were obtained after 48hours, mechanically disaggregated, pooled,
stained with phycoerythrin-labeled antibody against mouse CD11c (clone HL3, hamster IgG; Pharmingen,
Heidelberg, Germany). CD11c, PKH2-GL double positive cells were quantified by a FACS. Using
Mann–Whitney rank-sum test the difference between the two groups is statistically significant (P¼ 0.042).
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